Product Name: 4-Iodo-3-nitrobenzamide CAS NO: 160003-66-7
Chemical & Physical Properties:
Appearance : yellow solid
Boiling Point:344.75℃ at 760 mmHg
Iniparib (previously BSI 201) (4-iodo-3-nitrobenzamide) was a drug candidate for cancer treatment. It was originally believed to act as an irreversible inhibitor of PARP1 (hence, a PARP inhibitor) and possibly other enzymes through covalent modification, but its effects against PARP were later disproven. It underwent clinical trials for treatment of some types of breast cancer, but was discontinued after disappointing Phase III clinical trials.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.